APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hypnotics and Sedatives

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hypnotics and Sedatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchHypnotics and Sedatives Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Hypnotics and Sedatives Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Hypnotics and Sedatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hypnotics and Sedatives Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Hypnotics and Sedatives Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Hypnotics and Sedatives market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hypnotics and Sedatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hypnotics and Sedatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hypnotics and Sedatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hypnotics and Sedatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hypnotics and Sedatives include Abbott, Takeda, Sanofi, Novartis, Mylan, Pfizer, Fresenius Kabi, Baxter and Sands Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hypnotics and Sedatives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hypnotics and Sedatives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hypnotics and Sedatives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hypnotics and Sedatives market size, projected growth trends, production technologies, key applications, and end-use industries.

Hypnotics and Sedatives Segment by Company

Abbott

Takeda

Sanofi

Novartis

Mylan

Pfizer

Fresenius Kabi

Baxter

Sands Pharm

Hospira

Cobalt Laboratories

Hypnotics and Sedatives Segment by Type

Capsule

Solution

Suppository

Injectable

Hypnotics and Sedatives Segment by Application

Hospital

Clinic

Hypnotics and Sedatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hypnotics and Sedatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hypnotics and Sedatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hypnotics and Sedatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hypnotics and Sedatives market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hypnotics and Sedatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hypnotics and Sedatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hypnotics and Sedatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hypnotics and Sedatives Industry Trends Table 2. Hypnotics and Sedatives Industry Drivers Table 3. Hypnotics and Sedatives Industry Opportunities and Challenges Table 4. Hypnotics and Sedatives Industry Restraints Table 5. Global Hypnotics and Sedatives Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hypnotics and Sedatives Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hypnotics and Sedatives Sales by Manufacturers (k tons) & (2021-2026) Table 8. Global Hypnotics and Sedatives Sales Market Share by Manufacturers Table 9. Global Hypnotics and Sedatives Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global Hypnotics and Sedatives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hypnotics and Sedatives Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hypnotics and Sedatives Manufacturers, Product Type & Application Table 13. Global Hypnotics and Sedatives Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hypnotics and Sedatives by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Capsule Table 17. Major Manufacturers of Solution Table 18. Major Manufacturers of Suppository Table 19. Major Manufacturers of Injectable Table 20. Global Hypnotics and Sedatives Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 21. Global Hypnotics and Sedatives Sales by Type (2021-2026) & (k tons) Table 22. Global Hypnotics and Sedatives Sales by Type (2027-2032) & (k tons) Table 23. Global Hypnotics and Sedatives Sales Market Share by Type (2021-2026) Table 24. Global Hypnotics and Sedatives Sales Market Share by Type (2027-2032) Table 25. Global Hypnotics and Sedatives Revenue by Type 2021 VS 2025 VS 2032 (k tons) Table 26. Global Hypnotics and Sedatives Revenue by Type (2021-2026) & (k tons) Table 27. Global Hypnotics and Sedatives Revenue by Type (2027-2032) & (k tons) Table 28. Global Hypnotics and Sedatives Revenue Market Share by Type (2021-2026) Table 29. Global Hypnotics and Sedatives Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Global Hypnotics and Sedatives Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 33. Global Hypnotics and Sedatives Sales by Application (2021-2026) & (k tons) Table 34. Global Hypnotics and Sedatives Sales by Application (2027-2032) & (k tons) Table 35. Global Hypnotics and Sedatives Sales Market Share by Application (2021-2026) Table 36. Global Hypnotics and Sedatives Sales Market Share by Application (2027-2032) Table 37. Global Hypnotics and Sedatives Revenue by Application 2021 VS 2025 VS 2032 (k tons) Table 38. Global Hypnotics and Sedatives Revenue by Application (2021-2026) & (k tons) Table 39. Global Hypnotics and Sedatives Revenue by Application (2027-2032) & (k tons) Table 40. Global Hypnotics and Sedatives Revenue Market Share by Application (2021-2026) Table 41. Global Hypnotics and Sedatives Revenue Market Share by Application (2027-2032) Table 42. Global Hypnotics and Sedatives Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 43. Global Hypnotics and Sedatives Sales by Region (2021-2026) & (k tons) Table 44. Global Hypnotics and Sedatives Sales Market Share by Region (2021-2026) Table 45. Global Hypnotics and Sedatives Sales Forecasted by Region (2027-2032) & (k tons) Table 46. Global Hypnotics and Sedatives Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Hypnotics and Sedatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 48. North America Hypnotics and Sedatives Sales by Country (2021-2026) & (k tons) Table 49. North America Hypnotics and Sedatives Sales by Country (2027-2032) & (k tons) Table 50. Europe Hypnotics and Sedatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 51. Europe Hypnotics and Sedatives Sales by Country (2021-2026) & (k tons) Table 52. Europe Hypnotics and Sedatives Sales by Country (2027-2032) & (k tons) Table 53. Asia Pacific Hypnotics and Sedatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 54. Asia Pacific Hypnotics and Sedatives Sales by Country (2021-2026) & (k tons) Table 55. Asia Pacific Hypnotics and Sedatives Sales by Country (2027-2032) & (k tons) Table 56. South America, Middle East and Africa Hypnotics and Sedatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 57. South America, Middle East and Africa Hypnotics and Sedatives Sales by Country (2021-2026) & (k tons) Table 58. South America, Middle East and Africa Hypnotics and Sedatives Sales by Country (2027-2032) & (k tons) Table 59. Global Hypnotics and Sedatives Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Hypnotics and Sedatives Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Hypnotics and Sedatives Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Hypnotics and Sedatives Revenue Market Share by Region (2021-2026) Table 63. Global Hypnotics and Sedatives Revenue Market Share by Region (2027-2032) Table 64. Abbott Company Information Table 65. Abbott Business Overview Table 66. Abbott Hypnotics and Sedatives Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Abbott Hypnotics and Sedatives Product Portfolio Table 68. Abbott Recent Development Table 69. Takeda Company Information Table 70. Takeda Business Overview Table 71. Takeda Hypnotics and Sedatives Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Takeda Hypnotics and Sedatives Product Portfolio Table 73. Takeda Recent Development Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Hypnotics and Sedatives Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sanofi Hypnotics and Sedatives Product Portfolio Table 78. Sanofi Recent Development Table 79. Novartis Company Information Table 80. Novartis Business Overview Table 81. Novartis Hypnotics and Sedatives Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Novartis Hypnotics and Sedatives Product Portfolio Table 83. Novartis Recent Development Table 84. Mylan Company Information Table 85. Mylan Business Overview Table 86. Mylan Hypnotics and Sedatives Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Mylan Hypnotics and Sedatives Product Portfolio Table 88. Mylan Recent Development Table 89. Pfizer Company Information Table 90. Pfizer Business Overview Table 91. Pfizer Hypnotics and Sedatives Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Pfizer Hypnotics and Sedatives Product Portfolio Table 93. Pfizer Recent Development Table 94. Fresenius Kabi Company Information Table 95. Fresenius Kabi Business Overview Table 96. Fresenius Kabi Hypnotics and Sedatives Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Fresenius Kabi Hypnotics and Sedatives Product Portfolio Table 98. Fresenius Kabi Recent Development Table 99. Baxter Company Information Table 100. Baxter Business Overview Table 101. Baxter Hypnotics and Sedatives Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Baxter Hypnotics and Sedatives Product Portfolio Table 103. Baxter Recent Development Table 104. Sands Pharm Company Information Table 105. Sands Pharm Business Overview Table 106. Sands Pharm Hypnotics and Sedatives Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Sands Pharm Hypnotics and Sedatives Product Portfolio Table 108. Sands Pharm Recent Development Table 109. Hospira Company Information Table 110. Hospira Business Overview Table 111. Hospira Hypnotics and Sedatives Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Hospira Hypnotics and Sedatives Product Portfolio Table 113. Hospira Recent Development Table 114. Cobalt Laboratories Company Information Table 115. Cobalt Laboratories Business Overview Table 116. Cobalt Laboratories Hypnotics and Sedatives Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Cobalt Laboratories Hypnotics and Sedatives Product Portfolio Table 118. Cobalt Laboratories Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Hypnotics and Sedatives Distributors List Table 122. Hypnotics and Sedatives Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Hypnotics and Sedatives Product Image Figure 2. Global Hypnotics and Sedatives Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hypnotics and Sedatives Market Size (2021-2032) & (US$ Million) Figure 4. Global Hypnotics and Sedatives Sales (2021-2032) & (k tons) Figure 5. Global Hypnotics and Sedatives Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 Hypnotics and Sedatives Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Capsule Image Figure 9. Solution Image Figure 10. Suppository Image Figure 11. Injectable Image Figure 12. Global Hypnotics and Sedatives Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 13. Global Hypnotics and Sedatives Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Hypnotics and Sedatives Sales Market Share by Type (2021-2032) Figure 15. Global Hypnotics and Sedatives Revenue by Type (2021 VS 2025 VS 2032) & (k tons) Figure 16. Global Hypnotics and Sedatives Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Hypnotics and Sedatives Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Global Hypnotics and Sedatives Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 21. Global Hypnotics and Sedatives Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Hypnotics and Sedatives Sales Market Share by Application (2021-2032) Figure 23. Global Hypnotics and Sedatives Revenue by Application (2021 VS 2025 VS 2032) & (k tons) Figure 24. Global Hypnotics and Sedatives Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Hypnotics and Sedatives Revenue Market Share by Application (2021-2032) Figure 26. North America Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 27. North America Hypnotics and Sedatives Sales Market Share by Country (2021-2032) Figure 28. U.S. Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 29. Canada Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 30. Mexico Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 31. Europe Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 32. Europe Hypnotics and Sedatives Sales Market Share by Country (2021-2032) Figure 33. Germany Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 34. France Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 35. U.K. Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 36. Italy Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 37. Netherlands Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 38. Asia Pacific Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 39. Asia Pacific Hypnotics and Sedatives Sales Market Share by Country (2021-2032) Figure 40. China Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 41. Japan Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 42. South Korea Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 43. Southeast Asia Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 44. India Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 45. Australia Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 46. South America, Middle East and Africa Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 47. South America, Middle East and Africa Hypnotics and Sedatives Sales Market Share by Country (2021-2032) Figure 48. Brazil Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 49. South Africa Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 50. Saudi Arabia Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 51. Turkey Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 52. Argentina Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 53. UAE Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 54. Egypt Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 55. Chile Hypnotics and Sedatives Sales and Growth Rate (2021-2032) & (k tons) Figure 56. Global Hypnotics and Sedatives Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Hypnotics and Sedatives Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Hypnotics and Sedatives Revenue (2021-2032) & (US$ Million) Figure 59. North America Hypnotics and Sedatives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Hypnotics and Sedatives Revenue (2021-2032) & (US$ Million) Figure 61. Europe Hypnotics and Sedatives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Hypnotics and Sedatives Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Hypnotics and Sedatives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Hypnotics and Sedatives Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Hypnotics and Sedatives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Hypnotics and Sedatives Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Hypnotics and Sedatives Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Solution
  • Suppository
  • Injectable
Applications
  • Hospital
  • Clinic
Companies covered
  • Abbott
  • Takeda
  • Sanofi
  • Novartis
  • Mylan
  • Pfizer
  • Fresenius Kabi
  • Baxter
  • Sands Pharm
  • Hospira
  • Cobalt Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hypnotics and Sedatives Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hypnotics and Sedatives Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hypnotics and Sedatives Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hypnotics and Sedatives Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hypnotics and Sedatives Market Dynamics
  1. 2.1 Hypnotics and Sedatives Industry Trends
  2. 2.2 Hypnotics and Sedatives Industry Drivers
  3. 2.3 Hypnotics and Sedatives Industry Opportunities and Challenges
  4. 2.4 Hypnotics and Sedatives Industry Restraints
3 Hypnotics and Sedatives Market by Manufacturers
  1. 3.1 Global Hypnotics and Sedatives Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hypnotics and Sedatives Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hypnotics and Sedatives Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hypnotics and Sedatives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hypnotics and Sedatives Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hypnotics and Sedatives Manufacturers, Product Type & Application
  7. 3.7 Global Hypnotics and Sedatives Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hypnotics and Sedatives Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hypnotics and Sedatives Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hypnotics and Sedatives Tier 1, Tier 2, and Tier 3
4 Hypnotics and Sedatives Market by Type
  1. 4.1 Hypnotics and Sedatives Type Introduction
  2. 4.1.1 Capsule
  3. 4.1.2 Solution
  4. 4.1.3 Suppository
  5. 4.1.4 Injectable
  6. 4.2 Global Hypnotics and Sedatives Sales by Type
  7. 4.2.1 Global Hypnotics and Sedatives Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Hypnotics and Sedatives Sales by Type (2021-2032)
  9. 4.2.3 Global Hypnotics and Sedatives Sales Market Share by Type (2021-2032)
  10. 4.3 Global Hypnotics and Sedatives Revenue by Type
  11. 4.3.1 Global Hypnotics and Sedatives Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Hypnotics and Sedatives Revenue by Type (2021-2032)
  13. 4.3.3 Global Hypnotics and Sedatives Revenue Market Share by Type (2021-2032)
5 Hypnotics and Sedatives Market by Application
  1. 5.1 Hypnotics and Sedatives Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Hypnotics and Sedatives Sales by Application
  5. 5.2.1 Global Hypnotics and Sedatives Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hypnotics and Sedatives Sales by Application (2021-2032)
  7. 5.2.3 Global Hypnotics and Sedatives Sales Market Share by Application (2021-2032)
  8. 5.3 Global Hypnotics and Sedatives Revenue by Application
  9. 5.3.1 Global Hypnotics and Sedatives Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hypnotics and Sedatives Revenue by Application (2021-2032)
  11. 5.3.3 Global Hypnotics and Sedatives Revenue Market Share by Application (2021-2032)
6 Global Hypnotics and Sedatives Sales by Region
  1. 6.1 Global Hypnotics and Sedatives Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hypnotics and Sedatives Sales by Region (2021-2032)
  3. 6.2.1 Global Hypnotics and Sedatives Sales by Region (2021-2026)
  4. 6.2.2 Global Hypnotics and Sedatives Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hypnotics and Sedatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hypnotics and Sedatives Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hypnotics and Sedatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hypnotics and Sedatives Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hypnotics and Sedatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hypnotics and Sedatives Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hypnotics and Sedatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hypnotics and Sedatives Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hypnotics and Sedatives Revenue by Region
  1. 7.1 Global Hypnotics and Sedatives Revenue by Region
  2. 7.1.1 Global Hypnotics and Sedatives Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hypnotics and Sedatives Revenue by Region (2021-2026)
  4. 7.1.3 Global Hypnotics and Sedatives Revenue by Region (2027-2032)
  5. 7.1.4 Global Hypnotics and Sedatives Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hypnotics and Sedatives Revenue (2021-2032)
  8. 7.2.2 North America Hypnotics and Sedatives Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hypnotics and Sedatives Revenue (2021-2032)
  11. 7.3.2 Europe Hypnotics and Sedatives Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hypnotics and Sedatives Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hypnotics and Sedatives Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hypnotics and Sedatives Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hypnotics and Sedatives Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Hypnotics and Sedatives Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Hypnotics and Sedatives Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Takeda
  8. 8.2.1 Takeda Company Information
  9. 8.2.2 Takeda Business Overview
  10. 8.2.3 Takeda Hypnotics and Sedatives Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Hypnotics and Sedatives Product Portfolio
  12. 8.2.5 Takeda Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Hypnotics and Sedatives Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Hypnotics and Sedatives Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Hypnotics and Sedatives Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Hypnotics and Sedatives Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Hypnotics and Sedatives Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Hypnotics and Sedatives Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Hypnotics and Sedatives Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Hypnotics and Sedatives Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Fresenius Kabi
  38. 8.7.1 Fresenius Kabi Company Information
  39. 8.7.2 Fresenius Kabi Business Overview
  40. 8.7.3 Fresenius Kabi Hypnotics and Sedatives Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fresenius Kabi Hypnotics and Sedatives Product Portfolio
  42. 8.7.5 Fresenius Kabi Recent Developments
  43. 8.8 Baxter
  44. 8.8.1 Baxter Company Information
  45. 8.8.2 Baxter Business Overview
  46. 8.8.3 Baxter Hypnotics and Sedatives Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Baxter Hypnotics and Sedatives Product Portfolio
  48. 8.8.5 Baxter Recent Developments
  49. 8.9 Sands Pharm
  50. 8.9.1 Sands Pharm Company Information
  51. 8.9.2 Sands Pharm Business Overview
  52. 8.9.3 Sands Pharm Hypnotics and Sedatives Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sands Pharm Hypnotics and Sedatives Product Portfolio
  54. 8.9.5 Sands Pharm Recent Developments
  55. 8.10 Hospira
  56. 8.10.1 Hospira Company Information
  57. 8.10.2 Hospira Business Overview
  58. 8.10.3 Hospira Hypnotics and Sedatives Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hospira Hypnotics and Sedatives Product Portfolio
  60. 8.10.5 Hospira Recent Developments
  61. 8.11 Cobalt Laboratories
  62. 8.11.1 Cobalt Laboratories Company Information
  63. 8.11.2 Cobalt Laboratories Business Overview
  64. 8.11.3 Cobalt Laboratories Hypnotics and Sedatives Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cobalt Laboratories Hypnotics and Sedatives Product Portfolio
  66. 8.11.5 Cobalt Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hypnotics and Sedatives Value Chain Analysis
  2. 9.1.1 Hypnotics and Sedatives Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hypnotics and Sedatives Production Mode & Process
  6. 9.2 Hypnotics and Sedatives Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hypnotics and Sedatives Distributors
  9. 9.2.3 Hypnotics and Sedatives Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst